217 related articles for article (PubMed ID: 23547214)
1. Expression of peroxisome proliferator-activated receptors α, β, γ, and H- and L-prostaglandin D synthase during osteoarthritis in the spontaneous hartley guinea pig and experimental dog models.
Nebbaki SS; El Mansouri FE; Afif H; Kapoor M; Benderdour M; Pelletier JP; Martel-Pelletier J; Fahmi H
J Rheumatol; 2013 Jun; 40(6):877-90. PubMed ID: 23547214
[TBL] [Abstract][Full Text] [Related]
2. Role of Lipocalin-Type Prostaglandin D Synthase in Experimental Osteoarthritis.
Najar M; Ouhaddi Y; Paré F; Lussier B; Urade Y; Kapoor M; Pelletier JP; Martel-Pelletier J; Benderdour M; Fahmi H
Arthritis Rheumatol; 2020 Sep; 72(9):1524-1533. PubMed ID: 32336048
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, reduces the progression of experimental osteoarthritis in guinea pigs.
Kobayashi T; Notoya K; Naito T; Unno S; Nakamura A; Martel-Pelletier J; Pelletier JP
Arthritis Rheum; 2005 Feb; 52(2):479-87. PubMed ID: 15692987
[TBL] [Abstract][Full Text] [Related]
4. L-PGDS deficiency accelerated the development of naturally occurring age-related osteoarthritis.
Ouhaddi Y; Najar M; Paré F; Lussier B; Urade Y; Benderdour M; Pelletier JP; Martel-Pelletier J; Fahmi H
Aging (Albany NY); 2020 Dec; 12(24):24778-24797. PubMed ID: 33361529
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors.
Pelletier JP; Lascau-Coman V; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Martel-Pelletier J
J Rheumatol; 1999 Sep; 26(9):2002-14. PubMed ID: 10493683
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of lipocalin-type prostaglandin D2 synthase in osteoarthritic cartilage.
Zayed N; Li X; Chabane N; Benderdour M; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
Arthritis Res Ther; 2008; 10(6):R146. PubMed ID: 19094210
[TBL] [Abstract][Full Text] [Related]
7. Stable expression of lipocalin-type prostaglandin D synthase in cultured preadipocytes impairs adipogenesis program independently of endogenous prostanoids.
Hossain MS; Chowdhury AA; Rahman MS; Nishimura K; Jisaka M; Nagaya T; Shono F; Yokota K
Exp Cell Res; 2012 Feb; 318(4):408-15. PubMed ID: 22100987
[TBL] [Abstract][Full Text] [Related]
8. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase.
Pelletier JP; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Di Battista JA; Martel-Pelletier J
Arthritis Rheum; 1998 Jul; 41(7):1275-86. PubMed ID: 9663486
[TBL] [Abstract][Full Text] [Related]
9. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
Sabatini M; Lesur C; Thomas M; Chomel A; Anract P; de Nanteuil G; Pastoureau P
Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085
[TBL] [Abstract][Full Text] [Related]
10. Chondrocyte death in experimental osteoarthritis is mediated by MEK 1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase.
Pelletier JP; Fernandes JC; Jovanovic DV; Reboul P; Martel-Pelletier J
J Rheumatol; 2001 Nov; 28(11):2509-19. PubMed ID: 11708426
[TBL] [Abstract][Full Text] [Related]
11. Oral treatment with PD-0200347, an alpha2delta ligand, reduces the development of experimental osteoarthritis by inhibiting metalloproteinases and inducible nitric oxide synthase gene expression and synthesis in cartilage chondrocytes.
Boileau C; Martel-Pelletier J; Brunet J; Tardif G; Schrier D; Flory C; El-Kattan A; Boily M; Pelletier JP
Arthritis Rheum; 2005 Feb; 52(2):488-500. PubMed ID: 15693013
[TBL] [Abstract][Full Text] [Related]
12. Role of peroxisome proliferator-activated receptors in osteoarthritis (Review).
Huang G; Jiang W; Xie W; Lu W; Zhu W; Deng Z
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355371
[TBL] [Abstract][Full Text] [Related]
13. The peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: in vivo protective effects mediated through the inhibition of key signaling and catabolic pathways.
Boileau C; Martel-Pelletier J; Fahmi H; Mineau F; Boily M; Pelletier JP
Arthritis Rheum; 2007 Jul; 56(7):2288-98. PubMed ID: 17599749
[TBL] [Abstract][Full Text] [Related]
14. Degeneration of normal articular cartilage induced by late phase osteoarthritic synovial fluid in beagle dogs.
Xu QR; Dong YH; Chen SL; Bao CD; Du H
Tissue Cell; 2009 Feb; 41(1):13-22. PubMed ID: 18692211
[TBL] [Abstract][Full Text] [Related]
15. Global analyses of gene expression in early experimental osteoarthritis.
Appleton CT; Pitelka V; Henry J; Beier F
Arthritis Rheum; 2007 Jun; 56(6):1854-68. PubMed ID: 17530714
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level.
Pelletier JP; Jovanovic DV; Lascau-Coman V; Fernandes JC; Manning PT; Connor JR; Currie MG; Martel-Pelletier J
Arthritis Rheum; 2000 Jun; 43(6):1290-9. PubMed ID: 10857787
[TBL] [Abstract][Full Text] [Related]
17. Chondrocyte calcium-sensing receptor expression is up-regulated in early guinea pig knee osteoarthritis and modulates PTHrP, MMP-13, and TIMP-3 expression.
Burton DW; Foster M; Johnson KA; Hiramoto M; Deftos LJ; Terkeltaub R
Osteoarthritis Cartilage; 2005 May; 13(5):395-404. PubMed ID: 15882563
[TBL] [Abstract][Full Text] [Related]
18. Adult cartilage-specific peroxisome proliferator-activated receptor gamma knockout mice exhibit the spontaneous osteoarthritis phenotype.
Vasheghani F; Monemdjou R; Fahmi H; Zhang Y; Perez G; Blati M; St-Arnaud R; Pelletier JP; Beier F; Martel-Pelletier J; Kapoor M
Am J Pathol; 2013 Apr; 182(4):1099-106. PubMed ID: 23375622
[TBL] [Abstract][Full Text] [Related]
19. The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide.
Boileau C; Martel-Pelletier J; Moldovan F; Jouzeau JY; Netter P; Manning PT; Pelletier JP
Arthritis Rheum; 2002 Oct; 46(10):2637-47. PubMed ID: 12384922
[TBL] [Abstract][Full Text] [Related]
20. Oral treatment with a Brachystemma calycinum D don plant extract reduces disease symptoms and the development of cartilage lesions in experimental dog osteoarthritis: inhibition of protease-activated receptor 2.
Boileau C; Martel-Pelletier J; Caron J; Paré F; Troncy E; Moreau M; Pelletier JP
Ann Rheum Dis; 2010 Jun; 69(6):1179-84. PubMed ID: 19546097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
